SEC 13F Intelligence

Managers / Q4 2019 · view latest →

Granite Point Capital Management, L.P.

CIK 0001599562 · 109 STATE STREET, 5TH FLOOR, BOSTON, MA, 02109 · 617-587-7507

Reported Value
$641M
Q4 2019
Positions
88
Filings on Record
19
2019–present window
Filed
Feb 10, 2020
original filing

Summary

Granite Point Capital Management, L.P. reported $641M in U.S.-listed holdings across 88 positions for Q4 2019.

Its largest position, META, represents 1.0% of the portfolio.

Compared with Q3 2019, the fund opened 36 new positions and exited 16.

Portfolio Metrics

Turnover
+61.2%
vs prior filed quarter
Top-10 Concentration
+8.5%
share of reported value
Largest Position
+1.0%
Facebook
New / Exited
36 / 16
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $1.0BQ1 ’19Q2 ’19: $1.5BQ3 ’19: $639MQ4 ’19: $641MQ4 ’19Q1 ’20: $177MQ2 ’20: $2.0BQ3 ’20: $1.8BQ3 ’20Q4 ’20: $1.9BQ1 ’21: $2.7BQ2 ’21: $2.7BQ2 ’21Q3 ’21: $1.3BQ4 ’21: $590MQ1 ’22: $479MQ1 ’22Q2 ’22: $392MQ3 ’22: $247MQ4 ’22: $157MQ4 ’22Q1 ’23: $72MQ3 ’23: $0filingsflow.com

Portfolio Composition

By security type
ETP: 78.9%Common Stock: 15.9%ADR: 2.2%Other: 1.4%US DOMESTIC: 1.0%Right: 0.6%
  • ETP · 78.9% · $506M
  • Common Stock · 15.9% · $102M
  • ADR · 2.2% · $14M
  • Other · 1.4% · $9M
  • US DOMESTIC · 1.0% · $6M
  • Right · 0.6% · $4M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
QQQINVESCO QQQ TRNEW+850.0K850.0K+$181M$181M
GLDSPDR GOLD TRUSTNEW+300.0K300.0K+$43M$43M
XLESELECT SECTOR SPDR TRNEW+400.0K400.0K+$24M$24M
SPDR SERIES TRUSTNEW+500.0K500.0K+$12M$12M
XMESPDR SERIES TRUSTNEW+400.0K400.0K+$12M$12M
IGVISHARES TRNEW+40.0K40.0K+$9M$9M
IYRISHARES TRNEW+100.0K100.0K+$9M$9M
ARQULE INCNEW+300.0K300.0K+$6M$6M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2019

71 positions (from 72 filing rows — )
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1METAFACEBOOK INChistory →CL A1.04%$7M32.4K
2SIENTRA INCCOM0.98%$6M701.0K
3MARINUS PHARMACEUTICALS INCCOM0.91%$6M2.70M
4TILRAY INCDEBT 5.000%10/00.89%$6M11.00M
5AMDADVANCED MICRO DEVICES INCNOTE 2.125% 9/0 · COM0.88%$6M560.0K
6GOOGLALPHABET INCCAP STK CL A0.86%$6M4.1K
7BOOTBOOT BARN HLDGS INCCOM0.75%$5M107.4K
8EVERBRIDGE INCCOM0.74%$5M61.0K
9AMZNAMAZON COM INCCOM0.72%$5M2.5K
10ZOGENIX INCCOM NEW0.70%$5M86.6K
11BRISTOL MYERS SQUIBB CORIGHT 99/99/99990.59%$4M1.25M
12XENEXENON PHARMACEUTICALS INCCOM0.56%$4M272.5K
13IMVTIMMUNOVANT INCCOM0.55%$3M220.0K
14XCUREXICURE INCCOM0.46%$3M1.02M
15MOMO INCADR0.44%$3M85.0K
16LULULULULEMON ATHLETICA INCCOM0.44%$3M12.2K
17DECIPHERA PHARMACEUTICALS INCOM0.41%$3M42.0K
18LUMENTUM HLDGS INCNOTE 0.250% 3/10.39%$2M1.70M
19CDNACAREDX INCCOM0.39%$2M114.7K
20BABAALIBABA GROUP HLDG LTDSPONSORED ADS0.38%$2M11.5K
21TNDMTANDEM DIABETES CARE INCCOM NEW0.37%$2M40.0K
22FIVEFIVE BELOW INCCOM0.34%$2M17.0K
23MUMICRON TECHNOLOGY INCCOM0.34%$2M40.0K
24DIREXION SHS ETF TRCSI 300 BULL2X0.33%$2M87.3K
25AUPHAURINIA PHARMACEUTICALS INCCOM0.32%$2M100.0K
26ZENDESK INCCOM0.31%$2M26.0K
27TALTAL EDUCATION GROUPSPONSORED ADS0.31%$2M40.9K
28PYPLPAYPAL HLDGS INCCOM0.30%$2M18.0K
29SESEA LTDSPONSORED ADS0.29%$2M45.6K
30OLLIOLLIES BARGAIN OUTLT HLDGS ICOM0.24%$2M24.0K
31GOOSCANADA GOOSE HOLDINGS INCSHS SUB VTG0.23%$1M40.0K
32OVIDOVID THERAPEUTICS INCCOM0.23%$1M348.3K
33TSLATESLA INCCOM0.20%$1M3.0K
34ZUMZZUMIEZ INCCOM0.19%$1M35.0K
35AAPLAPPLE INCCOM0.18%$1M4.0K
36URBNURBAN OUTFITTERS INCCOM0.17%$1M40.0K
37DMACDIAMEDICA THERAPEUTICS INCCOM NEW0.17%$1M227.2K
38SUTRO BIOPHARMA INCCOM0.17%$1M100.0K
39DQDAQO NEW ENERGY CORPSPNSRD ADR NEW0.16%$1M19.7K
40SNAPSNAP INCCL A0.15%$980,00060.0K
41RNGRINGCENTRAL INCCL A0.15%$932,0005.5K
42AQSTAQUESTIVE THERAPEUTICS INCCOM0.15%$932,000160.1K
43KRANESHARES TRCSI CHI INTERNET0.14%$910,00018.7K
44AXGNAXOGEN INCCOM0.14%$895,00050.0K
45MOTUS GI HLDGS INCCOM0.12%$763,000333.3K
46MAGNACHIP SEMICONDUCTOR SANOTE 5.000% 3/00.12%$754,000500.0K
47VIPSVIPSHOP HLDGS LTDSPONSORED ADS A0.11%$709,00050.0K
48NVDANVIDIA CORPCOM0.11%$706,0003.0K
49AFYA LTDCL A COM0.10%$656,00024.2K
50VICRVICOR CORPCOM0.10%$645,00013.8K
51BILIBILIBILI INCSPONS ADS REP Z0.10%$616,00033.1K
52NTESNETEASE INCSPONSORED ADS0.10%$613,0002.0K
53NEW ORIENTAL ED & TECH GRP ISPON ADR0.09%$606,0005.0K
54AKTSQAKOUSTIS TECHNOLOGIES INCCOM0.09%$600,00075.0K
55LXLEXINFINTECH HLDGS LTDADR0.09%$600,00043.2K
56INFINERA CORPORATIONCOM0.06%$397,00050.0K
57CHANGYOU COM LTDADS REP CL A0.06%$381,00039.0K
58STOKSTOKE THERAPEUTICS INCCOM0.06%$374,00013.2K
59ENPHENPHASE ENERGY INCCOM0.06%$366,00014.0K
60MLCOMELCO RESORTS AND ENTMT LTDADR0.06%$363,00015.0K
61APLTAPPLIED THERAPEUTICS INCCOM0.05%$325,00011.9K
62VYGRVOYAGER THERAPEUTICS INCCOM0.04%$246,00017.6K
63QFIN360 FINANCE INCADS0.04%$244,00025.0K
64GLOBAL EAGLE ENTMT INCNOTE 2.750% 2/10.04%$241,000500.0K
65ESTAESTABLISHMENT LABS HLDGS INCCOM0.04%$238,0008.6K
66WBWEIBO CORPSPONSORED ADR0.04%$232,0005.0K
67NTCTNETSCOUT SYS INCCOM0.04%$231,0009.6K
68TURNING POINT THERAPEUTICS ICOM0.04%$230,0003.7K
69CLLSCELLECTIS S ASPONSORED ADS0.03%$171,00010.0K
70BEASLEY BROADCAST GROUP INCCL A0.03%$170,00055.2K
71SDCCQSMILEDIRECTCLUB INCCL A COM0.03%$161,00018.4K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2023$01Nov 7, 202313F-HRchanges · EDGAR ↗
Q2 2023Under review1Aug 10, 202313F-HRchanges · EDGAR ↗
Q1 2023$72M52May 11, 202313F-HRchanges · EDGAR ↗
Q4 2022$157M90Feb 7, 202313F-HRchanges · EDGAR ↗
Q3 2022$247M103Nov 4, 202213F-HRchanges · EDGAR ↗
Q2 2022$392M108Aug 5, 202213F-HRchanges · EDGAR ↗
Q1 2022$479M125May 11, 202213F-HRchanges · EDGAR ↗
Q4 2021$590M127Feb 11, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.3B182Nov 10, 202113F-HRchanges · EDGAR ↗
Q2 2021$2.7B212Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$2.7B254May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.9B150Feb 5, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.8B164Nov 6, 202013F-HRchanges · EDGAR ↗
Q2 2020$2.0B140Aug 12, 202013F-HRchanges · EDGAR ↗
Q1 2020$177M72May 12, 202013F-HRchanges · EDGAR ↗
Q4 2019$641M88Feb 10, 202013F-HRchanges · EDGAR ↗
Q3 2019$639M68Oct 30, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.5B88Jul 29, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.0B108May 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.